On Friday, DR Horton stock earned an upgrade to its Relative Strength (RS) Rating, from 78 to 89.
This exclusive rating from Investor's Business Daily tracks share price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the top-performing stocks typically have an RS Rating of at least 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is DR Horton Stock A Buy?
DR Horton stock has climbed more than 5% past a 157.72 entry in a first-stage double bottom, meaning it's now out of a proper buy range. Look for the stock to offer a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The homebuilder showed 5% EPS growth in the latest quarterly report, while sales growth came in at 2%.
DR Horton stock holds the No. 10 rank among its peers in the Building-Residential/Commercial industry group. Meritage Homes, Toll Brothers and PulteGroup are among the top 5 highly rated stocks within the group. For more industry news, check out "
Homebuilder Stocks To Watch And Real Estate Industry News."
